Risk factor
Good trading liquidity
Profitability factor
Overvalued vs peers
About
Headquartered in Chengdu, China, Sichuan Hebang Biotechnology Corporation Limited, which originated in 2002, operates as a multifaceted enterprise. The company's core activities revolve around the development and distribution of products spanning agricultural, chemical, and advanced materials sectors. Its agricultural portfolio features biological pesticides, veterinary biological pharmaceuticals, and methionine. Within the chemical division, key offerings include sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. Additionally, the firm is a producer of various glass types, such as standard, smart, specialized, and low-emissivity coated glass, alongside photovoltaic packaging and module components. Another significant business line involves the supply of oil and natural gas. The company rebranded to its present name in April 2021, having previously been known as SichuanHebang Biotechnology Co.,Ltd.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA, overvalued on P/FC.